These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 20085802)

  • 1. Hedgehog beyond medulloblastoma and basal cell carcinoma.
    Teglund S; Toftgård R
    Biochim Biophys Acta; 2010 Apr; 1805(2):181-208. PubMed ID: 20085802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of hedgehog signaling pathway inhibitors.
    Liu H; Gu D; Xie J
    Chin J Cancer; 2011 Jan; 30(1):13-26. PubMed ID: 21192841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with Hedgehog pathway inhibitors.
    Low JA; de Sauvage FJ
    J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulators of the hedgehog signaling pathway.
    Heretsch P; Tzagkaroulaki L; Giannis A
    Bioorg Med Chem; 2010 Sep; 18(18):6613-24. PubMed ID: 20708941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.
    Filocamo G; Brunetti M; Colaceci F; Sasso R; Tanori M; Pasquali E; Alfonsi R; Mancuso M; Saran A; Lahm A; Di Marcotullio L; Steinkühler C; Pazzaglia S
    Mol Cancer Ther; 2016 Jun; 15(6):1177-89. PubMed ID: 26960983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Hedgehog signalling in cancer.
    Marini KD; Payne BJ; Watkins DN; Martelotto LG
    Growth Factors; 2011 Dec; 29(6):221-34. PubMed ID: 21875383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.
    Scales SJ; de Sauvage FJ
    Trends Pharmacol Sci; 2009 Jun; 30(6):303-12. PubMed ID: 19443052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine Hedgehog signaling in cancer.
    Theunissen JW; de Sauvage FJ
    Cancer Res; 2009 Aug; 69(15):6007-10. PubMed ID: 19638582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma.
    Sternberg C; Gruber W; Eberl M; Tesanovic S; Stadler M; Elmer DP; Schlederer M; Grund S; Roos S; Wolff F; Kaur S; Mangelberger D; Lehrach H; Hache H; Wierling C; Laimer J; Lackner P; Wiederstein M; Kasper M; Risch A; Petzelbauer P; Moriggl R; Kenner L; Aberger F
    Int J Cancer; 2018 Dec; 143(11):2943-2954. PubMed ID: 29987839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
    Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
    Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.
    Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J
    Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy.
    Pak E; Segal RA
    Dev Cell; 2016 Aug; 38(4):333-44. PubMed ID: 27554855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
    Brechbiel J; Miller-Moslin K; Adjei AA
    Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies.
    Ruiz Salas V; Alegre M; Garcés JR; Puig L
    Expert Rev Anticancer Ther; 2014 Jun; 14(6):741-9. PubMed ID: 24611655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment.
    Caro I; Low JA
    Clin Cancer Res; 2010 Jul; 16(13):3335-9. PubMed ID: 20439455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Hedgehog pathway targets against basal cell carcinoma.
    Tang JY; So PL; Epstein EH
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):257-64. PubMed ID: 17276471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog signaling in skin cancers.
    Li C; Chi S; Xie J
    Cell Signal; 2011 Aug; 23(8):1235-43. PubMed ID: 21397013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway.
    Palmer CJ; Galan-Caridad JM; Weisberg SP; Lei L; Esquilin JM; Croft GF; Wainwright B; Canoll P; Owens DM; Reizis B
    Cancer Res; 2014 Oct; 74(20):5914-24. PubMed ID: 25164012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
    Kudchadkar R; Lewis K; Gonzalez R
    Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog inhibition as an anti-cancer strategy.
    Raju GP; Pham D
    Vitam Horm; 2012; 88():507-22. PubMed ID: 22391319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.